These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17854605)

  • 1. The natural history and the staging of chronic hepatitis B: time for reevaluation of the virus-host relationship based on molecular virology and immunopathogenesis considerations?
    Thompson A; Locarnini S; Visvanathan K
    Gastroenterology; 2007 Sep; 133(3):1031-5. PubMed ID: 17854605
    [No Abstract]   [Full Text] [Related]  

  • 2. Viral quasi-species evolution during hepatitis Be antigen seroconversion.
    Lim SG; Cheng Y; Guindon S; Seet BL; Lee LY; Hu P; Wasser S; Peter FJ; Tan T; Goode M; Rodrigo AG
    Gastroenterology; 2007 Sep; 133(3):951-8. PubMed ID: 17854598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viremia profiles in hepatitis B virus carrier children with spontaneous e antigen seroconversion: a case of déjà vu?
    Lin CL; Kao JH
    Gastroenterology; 2007 Sep; 133(3):1052-3; author reply 1053-4. PubMed ID: 17854613
    [No Abstract]   [Full Text] [Related]  

  • 4. The emergence of envelope and precore/core variants of hepatitis B virus: the potential role of antibody selection.
    Thomas HC
    J Hepatol; 1995; 22(1 Suppl):1-8. PubMed ID: 7602059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of hepatitis B viral factors and advanced liver disease in HBeAg-negative patients: the more, the worse?
    Lin CL; Branch RA; Kao JH
    Gastroenterology; 2008 Apr; 134(4):1270-1; author reply 1271. PubMed ID: 18395114
    [No Abstract]   [Full Text] [Related]  

  • 6. Precore stop mutant in anti-HBe-positive phases of chronic hepatitis B virus infection.
    Chu CM
    Am J Gastroenterol; 2002 Aug; 97(8):2138-9; author reply 2139-40. PubMed ID: 12190193
    [No Abstract]   [Full Text] [Related]  

  • 7. [A study on quasispecies of HBV precore in liver tissue and serum in fulminant hepatitis B patients].
    Zhao XL; Wang YM; Lan L; Huang YP
    Zhonghua Gan Zang Bing Za Zhi; 2005 Aug; 13(8):612-3. PubMed ID: 16092993
    [No Abstract]   [Full Text] [Related]  

  • 8. HBeAg-negative chronic hepatitis B: from obscurity to prominence.
    Manesis EK
    J Hepatol; 2006 Sep; 45(3):343-6. PubMed ID: 16854495
    [No Abstract]   [Full Text] [Related]  

  • 9. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
    Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core promoter mutations of hepatitis B virus and hepatocellular carcinoma: story beyond A1762T/G1764A mutations.
    Liu CJ; Kao JH
    J Gastroenterol Hepatol; 2008 Mar; 23(3):347-50. PubMed ID: 18318819
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
    Lin CL; Kao JH
    J Biomed Sci; 2008 Mar; 15(2):137-45. PubMed ID: 18058038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
    Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
    J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What you need to know: interpreting hepatitis B viral markers.
    Tan CK
    Singapore Med J; 1998 Mar; 39(3):139-40. PubMed ID: 9632977
    [No Abstract]   [Full Text] [Related]  

  • 14. Need to strictly define hepatitis B virus immunotolerant patients to avoid unnecessary liver biopsy.
    Andreani T; Serfaty L; Poupon R; Chazouilleres O
    Gastroenterology; 2008 Dec; 135(6):2155-6. PubMed ID: 19000682
    [No Abstract]   [Full Text] [Related]  

  • 15. Benign course of long-standing hepatitis B virus infection among Greenland Inuit?
    Krarup HB; Andersen S; Madsen PH; Okkels H; Hvingel BH; Laurberg P
    Scand J Gastroenterol; 2008 Mar; 43(3):334-43. PubMed ID: 18266176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of chronic hepatitis B.
    Lai CL; Yuen MF
    J Viral Hepat; 2007 Nov; 14 Suppl 1():6-10. PubMed ID: 17958636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances on antigen-antibody immunogenic complex therapeutic vaccine for viral hepatitis B].
    Wang XY; Yao X; Guo LM; Xu LF; Shen XL; Xu DZ; Zhao K; Wen YM
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):718-20. PubMed ID: 19785971
    [No Abstract]   [Full Text] [Related]  

  • 18. [Characteristics of hepatitis B viral strains in chronic carrier patients from North-East Algeria].
    Khelifa F; Thibault V
    Pathol Biol (Paris); 2009 Feb; 57(1):107-13. PubMed ID: 18835106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective.
    Tan AT; Koh S; Goh V; Bertoletti A
    J Gastroenterol Hepatol; 2008 Jun; 23(6):833-43. PubMed ID: 18565018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genotype and mutation of hepatitis B virus and severe hepatitis].
    Hou JL; Zhou B
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):85-7. PubMed ID: 20196943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.